Our research systematically investigated that KIF18A expression was significantly linked with clinical features, prognosis, mutational status, DNA methylation, RNA methylation, TME, TMB, MSI, MMRs, and drug sensitivity in several cancers, which helped us to better understand the potential role of KIF18A in pan-cancer. This evidence concerns the gene KIF18A and cancer.